Journal of Clinical Trials
Open Access

Department of the Development of Molecular Tools for Diagnosis and Clinical Research (UDHM-DC), MiRNAX Biosens (Avda. Industria nº 4, Building 1) in Collaboration with Hospital Carlos III/ISCIII C/Sinesio Delgado 10, 28029-MADRID, Hospital L, Madrid, Spain

Publications

• Research Article   
  In vitro Characterisation and Clinical Evaluation of the Diagnostic Accuracy of a New Antigen Test for SARS-CoV-2 Detection
  Author(s): Juan José Montoya Miñano, José M. Rubio, Ouahid Y, Lopez A, Madejon A, Gil-Garcia A.I, Ryan Hannam, Butler H.R.E and Pablo Castan*
  
  Quick, user-friendly and sensitive diagnostic tools are the key to controlling the spread of the SARS-CoV-2 pandemic in the new epidemiologic landscape. The aim of this work is to characterize a new COVID-19 antigen test that uses an innovative chromatographic Affimer®-based technology designed for the qualitative detection of SARS-CoV-2 antigen. As rapid technology to detect COVID-19, the test was extensively characterized in vitro. Once the analytical parameters of performance were set, the test system was challenged in a test field study. The aim of this study was to evaluate its diagnostic accuracy, as compared by the gold standard RT-PCR and other existing lateral flow tests... View More»
  

  Abstract HTML PDF